Predict your next investment

Macregen company logo
HEALTHCARE | Drug Development
macregen.com

See what CB Insights has to offer

About Macregen

Macregen is developing transformative therapies for the preservation and treatment of vision in patients suffering from age-related macular degeneration (AMD) and other eye diseases. Macregen and its partners seek to develop, register, and commercialize first-in-class breakthrough drugs, given alone or in combination with other drugs for the treatment of both dry and wet AMD.

Macregen Headquarter Location

4200 The Woods Drive

San Jose, California, 95136,

United States

Latest Macregen News

VIDEO: When treating AMD, ‘believe the B scans’

Jul 29, 2020

Healio Interview Disclosures: Curcio reports receiving research support from Genentech and Heidelberg Engineering, and is a stockholder with Macregen Inc. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio In this exclusive video, Christine A. Curcio, PhD, White-McKee endowed professor in ophthalmology in the department of ophthalmology and visual sciences at the University of Alabama at Birmingham, explains how hyperreflective foci — which are commonly detected during OCT B scans of patients with age-related macular degeneration — are “huge risk factors for the progression to atrophy.” Using cone and rod mediated vision, Curcio and her lab worked with clinicians to determine if there were “functional correlates to the presence of HRF,” and the findings were presented at this year’s virtual ARVO annual meeting. “We should believe the B scans, they will help us win AMD,” Curcio said. Reference Curcio CA, et al. Hyperreflective foci and specks are associated with delayed rod-mediated dark adaptation in non-neovascular age-related macular degeneration (AMD). Presented at: Association for Research in Vision and Ophthalmology annual meeting; June 12, 2020 (virtual meeting).

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Macregen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Macregen is included in 1 Expert Collection, including Eye Health.

E

Eye Health

711 items

Macregen Patents

Macregen has filed 6 patents.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Disorders of choroid and retina
  • Ophthalmology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/17/2018

2/2/2021

Diseases of the eye and adnexa, Disorders of choroid and retina, Ophthalmology, Rare diseases, Complement system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/17/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Diseases of the eye and adnexa, Disorders of choroid and retina, Ophthalmology, Rare diseases, Complement system

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.